Morgan Stanley Maintains Overweight Rating and $101 PT on Colgate-Palmolive
A report from Morgan Stanley reiterates its Overweight rating and $101 price target on Colgate-Palmolive (NYSE: CL).
In the report, Morgan Stanley writes, “We rate Colgate Overweight. We expect multiple expansion as results inflect positively going forward on easing comparisons, an improving pricing/cost gap, continued emerging markets strength, and better results in prior problem areas."
Colgate-Palmolive is currently trading down $0.01 from its $92.34 closing price on Friday.







